Travere Therapeutics TVTX
NASDAQ TVTX
$52.43 -0.15 (-0.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

Travere Therapeutics (TVTX) Long-Term Debt Issuances (2014 - 2022)

Updated

Travere Therapeutics' Long-Term Debt Issuances came in at $316.25 million for FY2022.

Analysis

Travere Therapeutics (TVTX) Long-Term Debt Issuances (2014 - 2022) Analysis & Trends

Going back to FY2012, Travere Therapeutics' Long-Term Debt Issuances data covers 4 years.

  • Long-Term Debt Issuances carries a four-year compound annual growth rate of 3.5% (FY2018 to FY2022).
  • The FY2022 figure represents the lowest annual Long-Term Debt Issuances since FY2018.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $276 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn -
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -
10 Travere Therapeutics 4.94 Bn 4.54 Bn 167.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 316.25 Mn
Sep 30, 2014 1.00 Mn
API Access

Travere Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=TVTX&period=max&api_key=YOUR_API_KEY